Sanofi India Limited has informed the Exchange Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi India Limited has submitted a disclosure to the stock exchange under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The specific subject matter of the disclosure is not detailed in the headline provided. Regulation 30 filings generally cover material corporate events such as changes in management, business agreements, financial results, or strategic decisions that could affect shareholders. Without further details from the full filing, the exact nature and scope of this disclosure cannot be determined.
The impact on shareholders depends entirely on what was disclosed. Investors should look for the detailed filing on the NSE/BSE website or the company's investor relations page to understand the specific event and assess any potential effect on the stock or business outlook.